# BlephaCura

## Facts

| | |
|---|---|
| Origin | Germany |
| Headquarters | Hallbergmoos |
| Owner | Optima Pharmazeutische GmbH |
| Status | Active |
| Distribution | Pharmacy |
| Website | https://blephacura.de/ |

BlephaCura is a German eyelid-hygiene range made by Optima Pharmazeutische GmbH, a family-run health-products company based in Hallbergmoos, Germany [2]. The products are designed for daily care of the lid margins, the narrow strip of skin where the lashes grow, in people with blepharitis (inflammation of the eyelid edges) and with dry or irritated eyes. The range covers cleansing solutions, an eyelid oil, sterile wipes, cotton pads and reusable warming masks.

The brand is best documented through a clinical study. In 2010 the University of Cologne ran a randomised trial comparing BlephaCura with diluted baby shampoo, the conventional home remedy for cleaning inflamed eyelids, with Optima listed as a collaborator [11]. BlephaCura remains active, with a live product website and new product documentation published in October 2026.

## Origin & founders

The year BlephaCura was launched is not publicly stated, and no individual founder is credited with creating it. The brand grew out of its parent company's long specialisation in eye care. Optima Pharmazeutische GmbH was founded in Germany in 1984 [10], and its original product line consisted of generic ophthalmic medicines, that is, off-patent drugs for the eyes.

The earliest dated evidence of the brand itself is the Cologne study of 2010. Its registry entry describes the product under test as a solution with liposomes used for cleaning the eyelid to treat blepharitis [11], which matches the liposomal suspension still at the centre of the range today. The brand therefore existed in substantially its present form by that year.

## History & milestones

Optima's own history traces a gradual move away from prescription drugs. According to the company, it added ear, nose and throat care to its eye-care business in 1990, and from 2000 shifted its main focus to developing medical devices and health products [10]. BlephaCura fits that second phase: a non-drug product for a common, chronic eyelid condition, sold over the counter.

The group expanded abroad in the same period. Optima Medical Swiss AG was founded in Switzerland in 2010, and Optima Sanità Srl followed in Italy in 2017. The parent states that its products are now available in Europe, the United Kingdom, Switzerland, Australia, New Zealand and Canada, although it does not break that list down by brand.

The 2010 trial is the main dated milestone specific to BlephaCura. It was led by the University Eye Hospital in Cologne, enrolled 144 patients, ran from May to December 2010 and is listed as completed.

## Ownership

BlephaCura belongs to Optima Pharmazeutische GmbH, which also operates the brand's website from its address at Am Söldnermoos 17 in Hallbergmoos [2]. No acquisitions or changes of ownership are documented.

Within Optima's portfolio, BlephaCura sits alongside other eye, ear, nose and throat brands, including Tears Again, Isogutt, tima-oculav, OtoCura, Otovent, Nozovent, LipoNasal, LipoNit, LipoSaliva and LipoAerosol. Several of these share the liposome-based approach seen in BlephaCura's lead products. The group describes its work as developing medical devices and cosmetic products for consumer health and well-being, with a particular focus on eye and airway care.

## Philosophy & positioning

BlephaCura's central idea is that eyelid hygiene works best as a routine rather than a single product. The company describes daily lid-margin care as a key measure for blepharitis and for dry and irritated eyes, and says the range brings together every important step of eyelid care, from gentle warming to thorough cleansing [1]. Its tagline translates as "your daily solution for clean and cared-for eyelids".

The brand sets this out as a three-step routine. First, the eyelids are warmed with a mask. Second, the lids are massaged. Third, the lid margins are cleaned with a surfactant-free suspension that does not need to be rinsed off.

The products sit on the boundary between cosmetics and medical care. They carry German and Austrian pharmacy product codes, and the brand's website directs buyers to local pharmacies while also linking to online retail. Optima says BlephaCura is recommended by specialist doctors [8].

## Products & innovation

The core of the range is BlephaCura Med, a 70 ml liposomal suspension for daily cleansing of sensitive, irritated eyelids and the skin around the eyes. Liposomes are tiny fat-based droplets; the formula relies on them instead of soap-like cleansing agents. The company says the formula removes crusts, flakes and secretions, can also be used to take off eye make-up, and is free from PEG, parabens and surfactants [5]. It describes the product as tested by both dermatologists and eye doctors.

BlephaCura Akut is a 20 ml formula aimed at acute flare-ups. According to the brand, it combines liposomes with salicylic acid and glycerin [6], and is free from PEG, parabens, surfactants, artificial fragrances and preservatives. It comes in a pump dispenser that, the company says, protects the contents from contamination and allows use for up to six months after opening.

Around these two cleansers the range adds supporting products:

- **Re-Balance eyelid oil**, which Optima describes as a blend of castor, almond, olive, peanut, soy and evening primrose oils with aloe vera and calendula extracts, intended to soften the skin.
- **SALINA lid-hygiene wipes**, sterile single-use wipes moistened only with a physiological saline solution.
- **Classic eye mask**, a gel mask that can be heated or cooled, and a **Premium eye mask** with a removable, washable cover.
- **BlephaCura pads**, cotton pads for applying the cleansers; the brand says they are made from organic cotton.
- **All-in-One set**, which packages the Classic mask, BlephaCura Med and pads as a complete starter routine.

No third-party certifications are documented for the BlephaCura products themselves. At group level, Optima publishes an ISO 13485 certificate, the international quality-management standard for medical-device makers.

## Science & innovation

BlephaCura's main scientific claim rests on the Cologne trial. The study compared a phospholipid liposome suspension with diluted baby shampoo for chronic blepharitis, randomly assigning patients to one of the two cleaning methods [11]. The principal investigator was Arno Hueber of the University of Cologne, which acted as lead sponsor.

The brand presents the outcome on its website. It says patients who cleaned their lids with BlephaCura suspension showed a markedly greater improvement than those who used baby shampoo, and cites a paper in the German ophthalmology journal *Der Ophthalmologe* (volume 110, issue 2) as the reference [4]. The registry entry itself records the study as completed but does not list results.

More broadly, Optima says that decades of work in eye and ear, nose and throat medicine, together with collaborations with scientific institutions, have produced more than 30 peer-reviewed publications on the effectiveness of its products [10]. The company does not specify how many of these concern BlephaCura.

## Current status

BlephaCura is active. Its German-language website lists the current range with pharmacy codes for Germany and Austria, and new instructions for use for BlephaCura Akut were published there in October 2026 [6]. The brand remains part of Optima Pharmazeutische GmbH, with no sign of a sale or merger. No official social media accounts are linked from the brand's website.

## Timeline {#belagg-timeline}

| Year | Event | Source |
|---|---|---|
| 1984 | Parent company Optima Pharmazeutische GmbH founded in Germany (parent's founding year, not BlephaCura's launch year) | https://www.optimapharma.de/optima-gruppe/ |
| 2010 | Randomised clinical study 'Blephacura Versus Baby Shampoo to Treat Blepharitis' (NCT01115192) run by the University of Cologne with Optima Pharmazeutische GmbH as collaborator; start 2010-05-01, completed 2010-12-31 | https://clinicaltrials.gov/study/NCT01115192 |

## Signature products {#belagg-products}

- **BlephaCura Med Lidpflege (liposomal suspension, 70 ml)** — BlephaCura Med Lidpflege mit Liposomen ist die ideale Lösung für die tägliche Pflege und Reinigung empfindlicher, gereizter Augenlider und der sensiblen Augenpartie. — https://blephacura.de/blephacura-produkte/blephacura-suspension/
- **BlephaCura Akut (20 ml)** — Die spezielle Formulierung von BlephaCura Akut wurde entwickelt, um akut gereizte Augenlider zu beruhigen und Beschwerden bei Lidrandentzündung (Blepharitis) zu lindern. — https://blephacura.de/blephacura-produkte/blephacura-akut/
- **BlephaCura Re-Balance Augenlid-Öl** — Regeneriert und macht die Haut geschmeidig mit der Kombination aus Rizinus-, Mandel-, Oliven-, Erdnuss-, Soja- und Nachtkerzenöl sowie Auszügen von Aloe Vera und Calendula. — https://www.optimapharma.de/blephacura/
- **BlephaCura SALINA Lidhygiene-Tücher** — Sterile, nur mit physiologischer Kochsalzlösung vorbefeuchtete Einmaltücher — https://www.optimapharma.de/blephacura/
- **BlephaCura All-in-One Lidpflege-Set (Classic Augenmaske + Med Lidpflege 70 ml + Pads)** — Die im Set enthaltene BlephaCura Med Lidpflege ist eine liposomale Suspension zur täglichen Reinigung und Pflege empfindlicher, gereizter Augenlider sowie der sensiblen Augenpartie. — https://blephacura.de/blephacura-produkte/all-in-one-set/

## Key ingredients {#belagg-ingredients}

liposomes · salicylic acid · glycerin

Source: https://blephacura.de/blephacura-produkte/blephacura-akut/

## Sources

1. (T1) https://blephacura.de/
2. (T2) https://blephacura.de/impressum/
4. (T2) https://blephacura.de/faq-lidrandentzeundung-lidpflege/
5. (T2) https://blephacura.de/blephacura-produkte/blephacura-suspension/
6. (T2) https://blephacura.de/blephacura-produkte/blephacura-akut/
8. (T2) https://www.optimapharma.de/blephacura/
10. (T2) https://www.optimapharma.de/optima-gruppe/
11. (T4) https://clinicaltrials.gov/study/NCT01115192

---

Glowpedia · <https://glowpedia.org/m/blephacura/> · Published 2026-10-06

Please cite with a link to the article URL.
